Cysticercosis vaccine: cross protecting immunity with T. solium antigens against experimental murine T. crassiceps cysticercosis.
about
Androgens Exert a Cysticidal Effect upon Taenia crassiceps by Disrupting Flame Cell Morphology and FunctionHeat shock and stress response of Taenia solium and T. crassiceps (Cestoda).Genetic vaccination against murine cysticercosis by using a plasmid vector carrying Taenia solium paramyosin.Increased resistance to Taenia crassiceps murine cysticercosis in Qa-2 transgenic mice.Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis.Two epitopes shared by Taenia crassiceps and Taenia solium confer protection against murine T. crassiceps cysticercosis along with a prominent T1 response.Characterization and protective potential of the immune response to Taenia solium paramyosin in a murine model of cysticercosisIdentification of loci controlling restriction of parasite growth in experimental Taenia crassiceps cysticercosis.Taenia solium: Development of an Experimental Model of Porcine Neurocysticercosis.Fact or hypothesis: Taenia crassiceps as a model for Taenia solium, and the S3Pvac vaccine.Heterologous prime-boost oral immunization with GK-1 peptide from Taenia crassiceps cysticerci induces protective immunityDepressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection.Host gender in parasitic infections of mammals: an evaluation of the female host supremacy paradigm.Successful immunization of naturally reared pigs against porcine cysticercosis with a recombinant oncosphere antigen vaccineCysticerci drive dendritic cells to promote in vitro and in vivo Tregs differentiation.Taenia crassiceps: in vivo and in vitro models.Development of the S3Pvac vaccine against murine Taenia crassiceps cysticercosis: a historical review.Development of the S3Pvac vaccine against porcine Taenia solium cysticercosis: a historical review.Experimental encephalitis caused by Taenia crassiceps cysticerci in mice.Genetic control of susceptibility to Taenia crassiceps cysticercosis.
P2860
Q27306108-8919B807-F637-4B60-803B-BB105516E701Q29304985-CA19A604-898E-4166-B9CB-FA9E107B96D8Q33716181-D3E1558F-4867-4A9C-AE88-2478B4D51785Q33750579-2F67C1AD-CCC4-4D73-A6F1-19FE32441693Q33867551-D6C25E0B-A323-43C3-AFE1-3846876AE017Q34006476-DA1E151C-3D4F-4945-9AC3-982C23ABDEF2Q34008863-66DFB4C1-C74D-4413-B06D-4D892D1D7365Q34113834-51D42985-79A3-44CC-94C8-8904CC27007FQ34488709-83000847-A084-4E5C-ACC9-95DA2768DEE5Q34551214-2EAEDCD3-02C5-4260-AA86-124FBEBC044DQ35138626-B0913805-2831-4CC7-9110-962BBAF83982Q35417944-B0EFAE36-C714-442D-9A72-0735ECAAB6BDQ35843344-AFBF675E-3D71-40DF-B28F-70D53DA8D8F9Q36167073-BD45BDF0-8B51-47F0-A35F-526B8152CF56Q36914233-ECC07C4E-DB45-40AB-94FE-12C9D988A50EQ37616235-7B939DAA-5E56-4151-8F64-1177DD80217EQ38081501-3056C0AC-E80B-4D74-954C-933DEDF525C2Q38085075-D262B7D8-22E5-470C-B741-9FC07AA1E1A3Q39225173-86AD82D4-310B-4F6F-A82E-6D3767F27EB7Q45254823-0F2D425F-0339-4C9C-BB62-80122851D687
P2860
Cysticercosis vaccine: cross protecting immunity with T. solium antigens against experimental murine T. crassiceps cysticercosis.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Cysticercosis vaccine: cross p ...... e T. crassiceps cysticercosis.
@en
Cysticercosis vaccine: cross p ...... e T. crassiceps cysticercosis.
@nl
type
label
Cysticercosis vaccine: cross p ...... e T. crassiceps cysticercosis.
@en
Cysticercosis vaccine: cross p ...... e T. crassiceps cysticercosis.
@nl
prefLabel
Cysticercosis vaccine: cross p ...... e T. crassiceps cysticercosis.
@en
Cysticercosis vaccine: cross p ...... e T. crassiceps cysticercosis.
@nl
P2093
P2860
P1433
P1476
Cysticercosis vaccine: cross p ...... e T. crassiceps cysticercosis.
@en
P2093
Govezensky T
Larralde C
Montoya RM
P2860
P304
P356
10.1111/J.1365-3024.1990.TB00997.X
P577
1990-11-01T00:00:00Z